We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
-1.76%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.58%
5 Year Est. Return
+121.05%
10 Year Est. Return
+327.07%
AUM
$1.04B
AUM Growth
-$33.4M
Cap. Flow
-$3.09M
Cap. Flow %
-0.3%
Top 10 Hldgs %
32.36%
Holding
422
New
84
Increased
51
Reduced
90
Closed
94

Top Buys

Rank Stock Value
1
OI icon
O-I Glass
OI
+$26M
2
UL icon
Unilever
UL
+$17.4M
3
GIIX
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
+$12.4M
4
T icon
AT&T
T
+$12.1M
5
PCG icon
PG&E
PCG
+$9.91M

Top Sells

Rank Stock Value
1
AXS icon
AXIS Capital
AXS
+$26.1M
2
C icon
Citigroup
C
+$23.8M
3
VYX icon
NCR Voyix
VYX
+$15.8M
4
HES
Hess
HES
+$9.65M
5
SONY icon
Sony
SONY
+$6.03M

Sector Composition

Rank Sector Weight
1 Financials 24.41%
2 Technology 14.74%
3 Communication Services 11.49%
4 Healthcare 10.24%
5 Consumer Discretionary 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GENI icon
301
Genius Sports
GENI
$2.12B
$46K ﹤0.01%
10,000
– –
ACTG icon
302
Acacia Research
ACTG
$455M
$45K ﹤0.01%
10,000
-34,911
-78% -$147K
ABTC
303
American Bitcoin Corp
ABTC
$505M
$43K ﹤0.01%
1
– –
KCGI.WS
304
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$38K ﹤0.01%
63,456
+2,331
+4% +$1.54K
TXN icon
305
Texas Instruments
TXN
$253B
$37K ﹤0.01%
+200
New +$35.3K
TTOO
306
DELISTED
T2 Biosystems, Inc
TTOO
$33K ﹤0.01%
13
-10
-43% -$21.2K
CNDA.WS
307
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$31K ﹤0.01%
+60,000
New +$39.7K
DMYS.WS
308
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$31K ﹤0.01%
44,633
+658
+1% +$536
SCRMW
309
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$30K ﹤0.01%
+49,992
New +$31.5K
XRX icon
310
Xerox
XRX
$412M
$29K ﹤0.01%
1,414
-24,000
-94% -$505K
BWCAW
311
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$28K ﹤0.01%
55,000
– –
CPS icon
312
Cooper-Standard Automotive
CPS
$490M
$26K ﹤0.01%
+3,000
New +$49.1K
PSTH.WS
313
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$24K ﹤0.01%
25,000
– –
KUST
314
Kustom Entertainment Inc
KUST
$708K
– –
0
– –
PRPB.WS
315
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$18K ﹤0.01%
17,500
– –
PRPC.WS
316
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$16K ﹤0.01%
26,046
+2,204
+9% +$1.58K
CIIGW
317
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$14K ﹤0.01%
+35,870
New +$18.2K
EPWR.WS
318
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$14K ﹤0.01%
71,353
– –
MSDAW
319
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$13K ﹤0.01%
16,282
+604
+4% +$518
ABLLW
320
DELISTED
Abacus Life Warrant
ABLLW
$12K ﹤0.01%
50,000
– –
EOCW.WS
321
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$12K ﹤0.01%
20,878
– –
SNRHW
322
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$10K ﹤0.01%
55,000
-20,000
-27% -$7.63K
RONI.WS
323
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$8K ﹤0.01%
12,498
– –
WAVC.WS
324
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
$7K ﹤0.01%
17,656
– –
PHICW
325
DELISTED
Population Health Investment Co., Inc. Warrant
PHICW
$6K ﹤0.01%
25,000
– –
11 12
13
14 15

Similar funds

RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
OA
Oak Associates Akron, Ohio $1.49B AUM 34.25% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

Levin Capital Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Levin Capital Strategies held 422 positions worth $1.04B, down 3.1% from $1.07B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Levin Capital Strategies's Q1 2022 filing shows 84 new, 51 increased, 90 reduced and 94 closed positions. Its largest new stake was O-I Glass: 1,995,892 shares worth $26.3M. The largest sale was AXIS Capital, an estimated $26.1M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.

  • Levin Capital Strategies's largest Q1 2022 buy was O-I Glass: 1,995,892 shares worth $26.3M.
  • Levin Capital Strategies added most to Unilever in Q1 2022, an estimated $17.4M increase.
  • Levin Capital Strategies's biggest Q1 2022 reduction was Citigroup, cutting an estimated $23.8M.
  • Levin Capital Strategies fully exited AXIS Capital in Q1 2022, selling an estimated $26.1M.
  • Levin Capital Strategies's ten largest holdings make up 32% of its $1.04B portfolio in Q1 2022.
  • Levin Capital Strategies opened 84 new positions and closed 94 in Q1 2022.
  • Levin Capital Strategies's portfolio value fell 3.1% quarter-over-quarter to $1.04B.

Based on Levin Capital Strategies's 13F filing for Q1 2022, filed 2 May 2022.